Signalling pathways mediating the transduction of information between cells are essential for development, cellular differentiation and homeostasis 1 . Their dysregulation is also frequently associated with human malignancies. The Janus tyrosine kinase/ signal transducer and activator of transcription (JAK/STAT) pathway represents one such signalling cascade whose evolutionarily conserved roles include cell proliferation and haematopoiesis 2 . Here we describe a systematic genome-wide survey for genes required for JAK/STAT pathway activity. Analysis of 20,026 RNA interference (RNAi)-induced phenotypes in cultured Drosophila melanogaster haemocyte-like cells identified interacting genes encoding 4 known and 86 previously uncharacterized proteins. Subsequently, cell-based epistasis experiments were used to classify these proteins on the basis of their interaction with known components of the signalling cascade. In addition to multiple human disease gene homologues, we have found the tyrosine phosphatase Ptp61F and the Drosophila homologue of BRWD3, a bromo-domain-containing protein disrupted in leukaemia 3 . Moreover, in vivo analysis demonstrates that disrupted dBRWD3 and overexpressed Ptp61F function as suppressors of leukaemialike blood cell tumours. This screen represents a comprehensive identification of novel loci required for JAK/STAT signalling and provides molecular insights into an important pathway relevant for human cancer. Human homologues of identified pathway modifiers may constitute targets for therapeutic interventions.
Developmental genetic screens in Drosophila have identified multiple JAK/STAT pathway components on the basis of their segmentation phenotype [4] [5] [6] , and subsequent analysis of the pathway has characterized evolutionarily conserved roles during immune responses, haematopoiesis and cellular proliferation [7] [8] [9] [10] . The JAK/ STAT signalling cascade in Drosophila comprises the extracellular ligand Unpaired (Upd) 5 , a transmembrane receptor with homology to the interleukin 6 (IL-6) receptor family termed Domeless (Dome) 11 , a single Janus tyrosine kinase (JAK) called Hopscotch (Hop) 4 and the Stat92E transcription factor 6, 12 (Fig. 1a) . Known regulators of JAK/STAT signalling, including a family of SOCS-like genes 13 , dPIAS/Su(var)2-10 (ref. 14) and STAM (ref. 15) , are functionally conserved and were identified based on their homology to components originally characterized in mammalian cell culture studies 2 . Although successful in identifying the pathway members Upd, Dome, Hop and Stat92E, it is probable that forward genetic approaches have missed components, possibly due to non-saturating mutagenesis, genetic redundancy or phenotypic pleiotropy.
In order to identify novel pathway components and circumvent limitations of classical genetic screens, we have undertaken a genome-wide RNAi screen, a powerful technique for the identification of new components of diverse cellular pathways [16] [17] [18] [19] . To this end, we devised a quantitative assay for JAK/STAT signalling activity in cultured Drosophila cells by multimerizing a STAT92E-binding site from the Draf promotor 20 to generate the 6 £ 2 £ DrafLuc firefly luciferase reporter. Given the role for JAK/STAT signalling in haematopoiesis 9 , we used Drosophila haemocyte-like Kc 167 cells because of their endogenous ability to respond to pathway activation (Fig. 1b) . On transfection of the 6 £ 2 £ DrafLuc reporter and a plasmid to constitutively express the ligand Upd, a robust induction of reporter gene activity was observed (Fig. 1b) . We examined whether depletion of known pathway components by RNAi 21 modifies JAK/STAT signalling activity in Kc 167 cells. We assessed the effect of doublestranded (ds)RNAs targeting the mRNA of the genes dome, stat92E and hop, as well as dsRNAs directed against the negative regulators socs36E and dPIAS. As shown in Fig. 1b , knock down of JAK/STAT components results in significant changes in reporter activity, whereas reporter activity in uninduced cells remains at low levels (Fig. 1b) .
We then set out to systematically identify genes required for JAK/ STAT signalling by generating a library of 20,026 dsRNAs targeting ,91% of the predicted transcripts in the Drosophila genome (see Supplementary Information). Using this library we performed duplicate genome-wide screens as outlined in Fig. 1c and Supplementary Fig. S1 . After computational analysis to identify candidate pathway modifiers ( Fig. 1d ; see also Supplementary Information), dsRNAs were resynthesized and assayed with an independent reporter, derived from the promoter of the pathway target gene socs36E 13 , to exclude reporter-specific artefacts. These approaches confirmed the identification of 67 dsRNAs that decrease pathway activity (putative positive regulators) and 24 dsRNAs that increase pathway activity (putative negative regulators) (see also Supplementary Materials and Table 1 ), targeting a total of 90 predicted genes. Although most modifiers are distributed throughout the genome ( Fig. 2a ; see also Supplementary Table 7) , the X chromosome appears to be devoid of negative regulators, a finding that may be linked to the role of the pathway in X:autosome ratio detection during Drosophila sex determination 22 . Based on Interpro and gene ontology (GO) annotations, pathway modifiers were classified according to their predicted functions (see Supplementary Information). Signalling factors, enzymes mediating post-translational protein modifications and transcription factors cumulatively represent 48% of the genes identified (Fig. 2b) . Examples include CG11501 encoding a putatively secreted, negative regulator of JAK/STAT signalling previously demonstrated to be a pathway target gene 8 , enok/CG11290 encoding an acetyl-transferase, and the tumour suppressor protein 101/CG9712 gene, which encodes a ubiquitin conjugating enzyme. The molecular role of these genes in the regulation of JAK/STAT signalling remains to be determined. Seventy-four per cent of the identified loci possess human homologues (E-values ,10 210 , compared to 62% for the whole proteome), of which 39% have been implicated in human disease (see Supplementary Tables 5 and 6) .
A genetic technique to characterize signalling molecules is the determination of their epistatic relationship with respect to defined pathway components. We therefore performed cell-based epistatic assays to determine the pathway response to expression of upd, Upd conditioned medium or expression of the constitutively active JAK allele hop Tuml (refs 5, 23) while simultaneously targeting a subset of positive regulators. In this way, dsRNA-inactivated genes required upstream in the pathway can be characterized on the basis of their rescue by pathway activation further downstream (Fig. 2c) . For example, although depletion of the g-interferon-related protein CG31694 results in downregulation of signalling stimulated by expression of upd, activation by Upd-conditioned medium or hop Tuml is unaffected (Fig. 2c) . This suggests that CG31694 is required for the production and/or activity of the Upd ligand. Conversely, loss of pathway activity resulting from the knock down of CG31132 cannot be rescued by any form of pathway stimulus, implying a function downstream of JAK (Fig. 2c) . Although this analysis suggests a role for multiple genes upstream of Dome, this classification is based on the lack of interaction observed under differing experimental conditions and the molecular basis of these results remains to be established.
In order to confirm the function of candidate genes in vivo, we tested examples of both positive and negative regulators of the JAK/ STAT signalling pathway. One positive regulator mentioned above is CG31132, which encodes a 2,232-amino-acid WD40-and bromodomain-containing protein homologous to human BRWD3 ( Fig. 3a; see also Supplementary Information). In the screen, a strong reduction of pathway activity was observed for two independent dsRNAs that target different regions of the transcript (Fig. 3a) . BRWD3 is a functionally uncharacterized locus recently identified at the break point of t(X;11)(q13;q23) translocations derived from multiple B cell chronic lymphocytic leukaemia (B-CLL) patients 3 . A previously uncharacterized mutagenic P element inserted in the fourth intron of CG31132 (hereafter termed dBRWD3 05842 ) has been generated by the Drosophila genome project 24 and its remobilization indicates that the transposon insertion is responsible for late embryonic lethality (see Supplementary Information). We therefore tested for genetic interactions between dBRWD3 and JAK/STAT signalling by crossing the dBRWD3 05842 allele to GMR-updD3 0 (ref.
25). The GMR-updD3
0 transgene ectopically misexpresses upd during eye development, resulting in cellular overproliferation and an enlarged adult eye (Fig. 3b, left panel) . Furthermore, removal of one copy of stat92E significantly suppresses eye overgrowth (Fig. 3b , middle panel) due to a reduction in the potency of JAK/STAT signalling 25 . Removal of a single copy of dBRWD3 was also able to suppress the GMR-updD3 0 phenotype (Fig. 3b, right panel) as expected for a Tuml is the overproliferation of haemocytes and the frequent formation of melanotic tumours, a phenotype described as a Drosophila model for leukaemia 23, 26 . We found that removal of one copy of dBRWD3 is sufficient to reduce the size and the frequency of hop Tuml -induced melanotic tumours ( Fig. 3c ; and see also Supplementary Table 3) . Moreover, homozygous escapers of a putative hypomorphic allele of dBRWD3, generated by excision of the original P-element, frequently develop ectopic wing vein material (Fig. 3d) , a phenotype reminiscent of the weak loss-of-function stat92E HJ allele 27 . Taken together, these experiments suggest a role for dBRWD3 in JAK/STAT signalling.
As a second example we analysed Ptp61F, a protein tyrosine phosphatase whose depletion led to an increase in JAK/STAT signalling activity. To perform an epistasis analysis we removed known pathway components and tested for the effect of simultaneously targeting ptp61F. Double RNAi against ptp61F together with lacZ, dome or hop results in pathway stimulation (Fig. 4a) . However, simultaneous removal of ptp61F and stat92E is sufficient to prevent signalling (Fig. 4a) . Loss of this phosphatase therefore results in the stimulation of Stat92E activity even in the absence of upstream components, indicating that Ptp61F negatively regulates the pathway downstream of JAK. We next asked whether Ptp61F also interferes with JAK/STAT signalling in vivo by using the cg-Gal4 driver to misexpress ptp61F in blood cells of hop Tuml mutants. Misexpression of ptp61Fc in a hop Tuml mutant background resulted in suppression of melanotic tumour formation, with the average frequency of large tumours reduced by approximately fourfold, an effect also observed after the misexpression of dPIAS 14 ( Fig. 4b ; see also Supplementary Table 3 ). Alternative splicing of ptp61F gives nuclear and cytoplasmic protein forms that both contain the same phosphatase domain 28 . However, the tumour suppressor phenotype is only observed with nuclear Ptp61Fc (Fig. 4c) , an effect that is reproduced by overexpression in cell culture (Fig. 4c) . These results are consistent with our identification of Ptp61F as a negative regulator of pathway activity and suggest that it may function by targeting phosphorylated, nuclear-localized Stat92E for deactivation.
Aberrant JAK/STAT signalling has been implicated in multiple human malignancies and its components have been proposed as molecular targets for the development of therapeutic compounds 29, 30 . The genome-wide screen presented here has identified known and previously unknown genes and we have characterized their probable level of interaction using cell-based epistasis analysis. Of the 90 JAK/STAT modifiers identified, many have human homologues that remain to be characterized. We have performed an analysis of two examples in vivo and demonstrate their roles in regulating the pathway in Drosophila. One of these is a homologue of human BRWD3, a gene recently identified at the break point of a translocation isolated from multiple B-CLL patients 3 . Given our functional analysis of dBRWD3 and the known roles for JAK/STAT signalling during normal haematopoiesis, it is possible that a breakdown in BRWD3-mediated STAT regulation may represent a molecular mechanism leading to the development of B-CLL. Thus, comprehensive genetic surveys by RNAi using Drosophila as a model organism represent a powerful approach for identifying targets relevant to human diseases. Information for details) . A Renilla luciferase reporter gene under the control of the constitutively active Actin5C promoter was co-transfected and used to monitor cell number (see Supplementary Information) . Genome-wide RNAi screening. A genome-wide RNAi library based on polymerase chain reaction (PCR) templates with an average length of 408 bp (flanked by T7-promotor binding sites) was generated by in vitro transcription 17 (see Supplementary Information). Primer and amplicon sequence information can be found at http://rnai.dkfz.de. For screening experiments, Drosophila Kc 167 cells were maintained in Schneider's medium (Invitrogen) supplemented with 10% fetal bovine serum (PAA) and 100 mg ml 21 penicillin-streptomycin (Invitrogen). A total of 57 384-well screening plates were loaded with approximately 75 nM dsRNA in 5 ml of 1 mM Tris at pH 7. Kc 167 cells were batch transfected with the appropriate reporters, pAct-Renilla and pAct-UpdGFP, and transferred to dsRNA-containing screening plates in serum-free medium after 7 h. For 384-well plates, 15,000 cells in 20 ml were dispensed per well using an automated liquid dispenser (MultiDrop, Thermo Labsystems) and incubated for 60 min before addition of serum-containing medium. After 5 d, medium was removed, cells were lysed and both firefly and Renilla luciferase activities were determined (see also Supplementary Information for computational analysis). Cell-based epistasis experiments. For epistasis experiments, cells were transfected with expression vectors to stimulate pathway activity (see below). After 7 h, 30,000 cells in 50 ml of serum-free medium were seeded into 96-well plates (Greiner) containing the dsRNAs to be tested (listed in Fig. 2c) . One hour later, 75 ml medium supplemented with 10% fetal bovine serum was added to the cells. Cells were lysed after 5 d and luciferase activity measured.
Each dsRNA was tested for its ability to suppress pathway activity under three conditions: (1) in Upd-expressing cells (screening conditions); (2) in cells treated with Upd-conditioned medium (Upd-CM); and (3) in cells expressing hop Tuml . Specifically, for Upd overexpression 5 £ 10 6 Kc 167 cells were transfected with 600 ng pAct-UpdGFP, 500 ng 6 £ 2 £ DrafLuc reporter, 250 ng pAc5.1-Sid-1, 25 ng pAct-RL and pAc5.1 to a total of 2 mg DNA. For Hop TumL overexpression, 5 £ 10 6 Kc 167 cells were transfected with 200 ng pAct-hop TumL , 500 ng 6 £ 2 £ DrafLuc reporter, 250 ng pAc5.1-Sid-1, 25 ng pAct-RL and pAc5.1 to a total of 2 mg DNA. To analyse processes upstream of Upd, two batches of cells were transfected separately to generate 'responder' and 'Upd-producer' cells. The responder cells were batch transfected with 500 ng 6 £ 2 £ DrafLuc reporter, 250 ng pAc5.1-Sid-1, 25 ng pAct-RL and pAc5.1 to a total of 2 mg plasmid DNA and subsequently seeded into 96-well plates containing the respective dsRNAs as described above. The Upd-producing cells were transfected with 2 mg pActUpdGFP and cultured in 10 cm dishes (Falcon). After 4 d, the cells were treated with 50 mg ml 21 heparin (Sigma) for 24 h and then the supernatant was collected, cleared by centrifugation and passed through a 0.2 mm filter (Millipore). 50 ml of this Upd-conditioned medium was then used to stimulate pathway activity in the responder cells for 24 h. Control medium from untransfected heparin-treated cells did not elicit pathway activity (data not shown). Epistasis analysis of ptp61F by double RNAi is described in Supplementary Information. Genetics. For genetic interaction assays, females of the stock y, w, hop Tuml ) and mutations in stat92E and dBRWD3. The haemocyte specific Gal4 driver line P[w þ , cg-Gal4.A]2 allowed specific misexpression constructs with upstream activating sequences (UAS) to be tested for their potential influence on tumour formation. Transgenic animals carrying UAS-EGFP or UAS-b-galactosidase were used as negative controls whereas UAS-dPIASGFP served as a positive control 14 (see Supplementary Table 3) .
Crosses were incubated at 25 8C and adult females heterozygous for the hop Tuml chromosome were scored within 24 h of eclosion for the presence of tumours, classified as small (one or two small melanotic spots as shown in Fig. 4b, right panel) or large (one or more large melanized growths or more than three small spots; Fig. 4b, left panel) . Survival rates for hop Tuml females seem to be independent of tumour frequency at the time point counted (data not shown). Assays were repeated at least twice for each genotype and a representative example from one experiment is shown (Fig. 4b) .
Genetic interaction with P[w þ , GMR-updD3 0 ] 0 19 (termed GMR-updD3 0 in the text) was undertaken as described 25 using OreR and stat92E 06346 as negative and positive controls, respectively. Suppression of GMR-updD3 0 -induced eye overgrowth by dBRWD3 05842 was observed in multiple independent experiments in a majority of individuals of the appropriate genotype. Drosophila heads were photographed using a Zeiss STEMI 2000-C binocular microscope and Axiocam camera.
